Societal CDMO Inc (DELISTED) (SCTL:DL)
1.10
0.00 (0.00%)
USD |
NASDAQ |
Apr 08, 16:00
Societal CDMO SG&A Expense (TTM): 21.02M for Dec. 31, 2023
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 21.02M |
September 30, 2023 | 21.25M |
June 30, 2023 | 21.02M |
March 31, 2023 | 20.91M |
December 31, 2022 | 21.95M |
September 30, 2022 | 21.24M |
June 30, 2022 | 20.77M |
March 31, 2022 | 19.40M |
December 31, 2021 | 18.37M |
September 30, 2021 | 17.08M |
June 30, 2021 | 16.89M |
March 31, 2021 | 17.36M |
December 31, 2020 | 18.12M |
September 30, 2020 | 18.00M |
June 30, 2020 | 17.58M |
March 31, 2020 | 18.85M |
December 31, 2019 | 19.91M |
September 30, 2019 | 1.023M |
June 30, 2019 | 4.002M |
March 31, 2019 | 11.42M |
December 31, 2018 | 14.44M |
September 30, 2018 | 26.78M |
Date | Value |
---|---|
June 30, 2018 | 26.44M |
March 31, 2018 | 19.81M |
December 31, 2017 | 14.32M |
September 30, 2017 | 20.47M |
June 30, 2017 | 17.67M |
March 31, 2017 | 14.12M |
December 31, 2016 | 12.74M |
September 30, 2016 | 13.79M |
June 30, 2016 | 13.42M |
March 31, 2016 | 13.26M |
December 31, 2015 | 12.99M |
September 30, 2015 | 9.691M |
June 30, 2015 | 7.297M |
March 31, 2015 | 5.659M |
December 31, 2014 | 3.920M |
September 30, 2014 | 2.780M |
June 30, 2014 | 1.857M |
March 31, 2014 | 1.101M |
December 31, 2013 | 0.5462M |
September 30, 2013 | 0.5566M |
June 30, 2013 | 0.4974M |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
1.023M
Minimum
Sep 2019
21.95M
Maximum
Dec 2022
17.62M
Average
18.85M
Median
Mar 2020
SG&A Expense (TTM) Benchmarks
XOMA Corp | 27.87M |
Ironwood Pharmaceuticals Inc | 164.80M |
CymaBay Therapeutics Inc (DELISTED) | 51.95M |
Homology Medicines Inc (DELISTED) | 31.26M |
Amgen Inc | 6.729B |